Britannia Life Sciences Inc. reported earnings results for the second quarter and six months ended September 30, 2022. For the second quarter, the company reported net income was CAD 1.08 million compared to net loss of CAD 0.799992 million a year ago. Basic earnings per share from continuing operations was CAD 0.01 compared to basic loss per share from continuing operations of CAD 0.01 a year ago.
For the six months, net income was CAD 4.57 million compared to net loss of CAD 0.176983 million a year ago. Basic earnings per share from continuing operations was CAD 0.03.